Neurosurgery News and Research

RSS

UC Berkeley, UCSF partner to help develop neural prostheses for brain repair

Neuroscientists and engineers at UCSF and UC Berkeley have joined forces to help pioneer a new frontier of brain repair - the development of devices that would allow patients with such conditions as stroke, spinal cord injury, traumatic brain injury and Lou Gehrig's disease to control prosthetics through thoughts alone.

25 Mar 2011

Quantum dots allow stem cell therapy monitoring for brain injury

A new technique using "quantum dots" produced through nanotechnology is a promising approach to monitoring the effects of stem cell therapies for stroke and other types of brain damage, reports the April issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

25 Mar 2011

FDA clears MASEP Infini's gamma ray neurosurgery system

MASEP Infini, an innovator in global medical technology, today announced 510(k) clearance from the U.S. Food and Drug Administration of its new Infini gamma ray neurosurgery system with patented Independent Beam Switch Control with Programmable Arcs, automated collimator exchange and three-dimensional patient positioning, and MASEP Infini's proven Rotary Focusing technology.

24 Mar 2011

$Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty$

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Medtronic of Canada Ltd. today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients.

23 Mar 2011

LDR submits two-level Mobi-C cervical artificial disc PMA to the FDA

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.

23 Mar 2011

IASIS enters definitive agreement to purchase 78.2% interest in St. Joseph Medical Center

IASIS Healthcare LLC today announced that it has entered into a definitive agreement to purchase a 78.2% interest in St. Joseph Medical Center, a 792-bed facility in downtown Houston, Texas.

19 Mar 2011

Medical Facilities fourth quarter consolidated facility service revenue increases 10.9% to $64.4 million

Medical Facilities Corporation, today reported its financial results for the three- and twelve-month periods ended December 31, 2010.

18 Mar 2011

Major clinical studies for heart disease, stroke fail to consider participant's ethnicity

Major clinical studies that evaluate prevention strategies for heart disease and stroke fail to consider a participant's ethnicity, a factor that can more than double the rate of death in some groups, according to research led by St. Michael's Dr. Joel Ray.

18 Mar 2011

Individualized dentritic cell vaccine may increase survival time in patients with glioblastoma

A dendritic cell vaccine personalized for each individual based on the patient's own tumor may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study at UCLA's Jonsson Comprehensive Cancer Center has found.

18 Mar 2011

St. Michael's receives $5 million McCain donation for therapeutic endoscopy program

Wallace and Margaret McCain have donated $5 million to St. Michael's Hospital for its therapeutic endoscopy program.

18 Mar 2011

Gene therapy holds promise for Parkinson's treatment

A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.

17 Mar 2011

Personalized dendritic cell vaccine may increase median survival in mesenchymal glioblastoma patients

17 Mar 2011

Naltrexone may be effective in women with specific genetic variation

Results from a new study suggest that one of the most prescribed medications for alcohol dependence may be more effective in some people. Preliminary results show that naltrexone, one of the only medications approved for treating people with alcohol abuse problems, may only be effective in women and those with a specific genetic variation.

17 Mar 2011

The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD

Neurologix, Inc., announced today that the results of the Company's Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease were published in an online-first edition of The Lancet Neurology.

17 Mar 2011

Results from first successful phase 2 trial of gene therapy for Parkinson's or any neurologic disorder

A gene therapy called NLX-P101 dramatically reduces movement impairment in Parkinson's patients, according to results of a Phase 2 study published today in the journal Lancet Neurology. The approach introduces a gene into the brain to normalize chemical signaling.

16 Mar 2011

Study: Bodychecking linked with brain injury among hockey players

Minor league hockey players in the Atom division are more than 10 times likely to suffer a brain injury since bodychecking was first allowed among the 9 and 10-year-olds, says a study led by St. Michael's Hospital neurosurgeon Dr. Michael Cusimano.

16 Mar 2011

Research links frequent prescribing to opioid-related deaths

Some physicians are prescribing opioids such as OxyContin 55 times as often as others, according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). The study found most opioid-related deaths occur among patients treated by physicians who frequently prescribe opioids, suggesting doctors who prescribe a lot of opioids may not be doing so safely.

15 Mar 2011

Neurogenesis plays a beneficial role in exercise-induced response to stress, sexual behavior and reproduction

Two studies published by an interdisciplinary team of Hong Kong researchers in the current special issue of Cell Transplantation (20:1), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/ , link the regrowth of key adult brain cells (neurogenesis) in two critical areas of the brain to both the benefits of exercise as a stress reducer and also to sexual behavior and reproductive issues.

11 Mar 2011

Organ removal surgery through body's orifices, without any visible incisions

The Chicago Park District physical instructor needed a way to get the surgery performed without being laid up for weeks so she opted for an innovative minimally invasive procedure called Natural Orifice Translumenal Endoscopic Surgery (NOTES) that would allow surgeons to perform organ removal surgery without any visible incisions and have her back on her feet the same day.

11 Mar 2011

Layton, LHP partner to construct new Seton Medical Center in Texas

LHP Hospital Group, Inc. of Plano, Texas, has announced the selection of Layton Construction Company, Inc. of Sandy, Utah, for construction of the new Seton Medical Center Harker Heights being developed in Harker Heights, Texas, by a joint venture between LHP and the Seton Family of Hospitals.

11 Mar 2011

Neurosurgery News and Research

UC Berkeley, UCSF partner to help develop neural prostheses for brain repair

Quantum dots allow stem cell therapy monitoring for brain injury

FDA clears MASEP Infini's gamma ray neurosurgery system

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

LDR submits two-level Mobi-C cervical artificial disc PMA to the FDA

IASIS enters definitive agreement to purchase 78.2% interest in St. Joseph Medical Center

Medical Facilities fourth quarter consolidated facility service revenue increases 10.9% to $64.4 million

Major clinical studies for heart disease, stroke fail to consider participant's ethnicity

Individualized dentritic cell vaccine may increase survival time in patients with glioblastoma

St. Michael's receives $5 million McCain donation for therapeutic endoscopy program

Gene therapy holds promise for Parkinson's treatment

Personalized dendritic cell vaccine may increase median survival in mesenchymal glioblastoma patients

Naltrexone may be effective in women with specific genetic variation

The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD

Results from first successful phase 2 trial of gene therapy for Parkinson's or any neurologic disorder

Study: Bodychecking linked with brain injury among hockey players

Research links frequent prescribing to opioid-related deaths

Neurogenesis plays a beneficial role in exercise-induced response to stress, sexual behavior and reproduction

Organ removal surgery through body's orifices, without any visible incisions

Layton, LHP partner to construct new Seton Medical Center in Texas

Neuroscience - Second Edition eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News